High-dose vitamin C: Promising treatment may extend survival of pancreatic cancer patients
A study published in the November issue of Redox Biology has found that adding intravenous, high-dose vitamin C to a chemotherapy regimen doubled the survival of patients with late-stage, metastatic pancreatic cancer from eight months to 16 months. “This is a deadly disease with very poor outcomes for patients. The median survival is eight months with treatment,…
Share